Jeffrey R. Jay, M.D.

Managing Partner

Dr. Jay has more than 30 years of private equity experience.  Prior to founding Great Point Partners in 2003, he was for 11 years a General Partner and the head of the health care group at J. H. Whitney & Co., an investment firm with over $6 billion in private equity, subordinated debt and hedge funds under management.

Dr. Jay has led numerous private equity investments and has been the chairman or a member of the boards of numerous companies including AdvancePCS (ADVP), Axiom, Biotronic NeuroNetwork, Clinical Supplies Management, Concentra Managed Care (CCMC), Cytovance Biologics, Eon Labs (ELAB), which was acquired by Novartis, Equian, MaSTherCell, MLM, iXCells, Softbox Systems, SteriPack, Symbion (SYMB), U.S. Bioservices, Valenz, Velentium and VetnCare.

Dr. Jay received his B.A. magna cum laude and his M.D. with honors from the six-year B.A./M.D. program at the Boston University School of Medicine and an M.B.A. from the Harvard Business School.  He is on the Dean’s Board of Advisors at the Boston University School of Medicine and  the Harvard Business School Health Care Advisory Board.

Select GPP Investments

  • American Surgical Professionals
  • Biotronic NeuroNetwork
  • Clinical Supplies Management
  • Corrona
  • Cytovance Biologics
  • Equian
  • MaSTherCell
  • MLM Medical Labs
  • Softbox Systems
  • Valenz


  • Harvard Business School, Healthcare Initiative Advisory Board
  • Boston University School of Medicine, Dean’s Board of Advisors